Latest filing published 12 Sept 2017 for Achieve Life Sciences, INC., €3,830.
Insider track record
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +1019.6%Entry US$5,720.00 · Close at T+365 US$64,042.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Scott Daniel Cormack: trading record in brief
This profile gathers the share dealings of Scott Daniel Cormack in Achieve Life Sciences, Inc. Over a trading history stretching from 21 August 2008 to 8 September 2017, the count stands at 71 filings.
Both buying and selling appear: 3 purchases worth €14k, against 13 sales worth €460k. Netting one side against the other leaves €447k of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 9 share grants and 34 option exercises.
In size, the median ticket on the buying side is €4,315. After 3 purchases with a full 90-day history, the hit rate stands at 100% and the median 90-day move at +70.4%. Past outcomes like these are no guarantee of what comes next.
On 12 September 2017 came the latest disclosure, a share grant for €3,830 in Achieve Life Sciences, Inc. The latest purchase dates back some time: it was published 6,614 days ago, on 29 September 2008. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Scott Daniel Cormack
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,491 shares@ US$3.0915.7% of flowCommon StockSEC:0001209191-17-052370:0
- 3,125 shares0Common StockSEC:0001209191-17-047593:0
- 1,590 shares0Common StockSEC:0001209191-17-047593:1
- 4,472 shares@ US$0.365.9% of flowCommon StockSEC:0001209191-17-039846:1
- 9,375 shares0Common StockSEC:0001209191-17-039846:0
- 5,000 shares0Common StockSEC:0001209191-17-039846:2
- 9,690 shares@ US$0.6323.6% of flowCommon StockSEC:0001209191-17-003460:1
- 20,312 shares0Common StockSEC:0001209191-17-003460:0
- 10,312 shares0Common StockSEC:0001209191-17-003460:2
- 9,375 shares0Common StockSEC:0001209191-16-128045:0
- 5,000 shares0Common StockSEC:0001209191-16-128045:2
- 4,856 shares@ US$1.0318.1% of flowCommon StockSEC:0001209191-16-128045:1
- 25,000 shares0Common StockSEC:0001209191-16-108923:0
- 12,033 shares@ US$0.8336.8% of flowCommon StockSEC:0001209191-16-108923:1
- 9,375 shares0Common StockSEC:0001209191-15-053693:0
- 4,571 shares@ US$2.69Common StockSEC:0001209191-15-053693:1
- 15,624 shares0Common StockSEC:0001209191-15-045582:0
- 7,543 shares@ US$1.88Common StockSEC:0001209191-15-045582:1
- 20,100 shares0Common StockSEC:0001209191-15-008039:0
- 9,206 shares@ US$2.11Common StockSEC:0001209191-15-008039:1
- 7,425 shares0Common StockSEC:0001209191-14-058752:0
- 3,401 shares@ US$3.06Common StockSEC:0001209191-14-058752:1
- 37,500 shares0Common StockSEC:0001209191-14-052440:0
- 18,341 shares@ US$3.17Common StockSEC:0001209191-14-052440:1
- 9,376 shares0Common StockSEC:0001209191-14-021636:0
25 of 71 declarations